ClaimLight
Menu

Drugs codes by Medicare payment, 2021

Every code billed to Original Medicare Part B, with how many providers bill it and what it paid.

Codes billed
401
of 6,253 codes · 2021
Medicare payment on the code
$10.7B
12% of all code payment · 2021
Services
878.9M
35% of all services on codes · 2021
Largest code
J0178
$2.60B paid, 24% of category payment · 2021
Change from prior year
–
Not compared: 2021 changed office visit values · 2021

Top 200 drugs codes

The 200 with the most payment of 265 codes.

Not listed: 136 codes billed by fewer than 11 providers (small cells; each has its own page with the count).

observed calculated calculated calculated calculated calculated
J0178Injection, aflibercept, 1 mg3,037$2,598,280,48524%3,546,845808
J9271Injection, pembrolizumab, 1 mg1,548$874,037,5538.2%21,421,85511,600
J2778Injection, ranibizumab, 0.1 mg1,445$797,320,6227.5%3,168,8501,015
J0897Injection, denosumab, 1 mg9,981$763,317,4107.2%46,983,0782,640
J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)1,147$494,732,8914.6%12,181,7728,475
90662Descriptor not shown (CPT code)81,422$442,090,0234.1%6,981,89050
J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)751$271,682,2872.5%47,180,23248,400
90694Descriptor not shown (CPT code)44,500$256,844,1182.4%4,003,27751
J1745Injection, infliximab, excludes biosimilar, 10 mg1,366$199,165,9881.9%6,041,6803,130
J1602Injection, golimumab, 1 mg, for intravenous use862$196,802,5111.8%14,449,21412,202
J9299Injection, nivolumab, 1 mg470$193,120,3111.8%8,574,71614,210
J0585Injection, onabotulinumtoxina, 1 unit3,344$179,443,2501.7%37,754,9617,282
J9312Injection, rituximab, 10 mg500$139,520,8611.3%2,009,3513,215
J7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg1,200$116,313,2441.1%8,642,3303,327
J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose2,095$112,717,1221.1%118,07736
J2505Injection, pegfilgrastim, 6 mg1,137$112,288,1321.1%53,62639
J2785Injection, regadenoson, 0.1 mg6,350$103,905,7950.98%2,206,248216
J2357Injection, omalizumab, 5 mg503$102,312,1370.96%3,461,2135,115
Q4159Affinity, per square centimeter128$101,302,7160.95%137,082690
J9217Leuprolide acetate (for depot suspension), 7.5 mg4,255$98,861,9650.93%699,235129
J3262Injection, tocilizumab, 1 mg417$87,590,3090.82%20,198,64239,240
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg425$77,711,8820.73%2,357,3903,520
J3380Injection, vedolizumab, intravenous, 1 mg407$76,803,5410.72%4,687,9248,100
J2350Injection, ocrelizumab, 1 mg96$76,083,0240.71%1,795,00114,701
90732Descriptor not shown (CPT code)29,822$75,872,6380.71%619,72216
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg332$68,609,7920.64%1,908,6464,266
J3111Injection, romosozumab-aqqg, 1 mg499$68,077,8070.64%9,337,61413,966
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj190$65,450,8700.61%1,842,8547,560
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)1,116$60,946,5740.57%23,235,37514,440
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg137$53,398,5470.50%1,446,6025,440
J1439Injection, ferric carboxymaltose, 1 mg1,337$49,591,6310.47%55,652,08030,000
90670Descriptor not shown (CPT code)10,529$49,212,6320.46%207,66815
Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg364$47,846,7170.45%951,1152,340
Q4197Puraply xt, per square centimeter92$47,127,5410.44%223,4242,120
J9035Injection, bevacizumab, 10 mg1,978$45,215,7250.42%833,180169
J7322Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg667$40,801,3150.38%1,621,8651,560
Q0138Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)1,372$38,690,7390.36%50,700,11025,500
J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg1,294$38,317,2570.36%2,696,0821,248
J3245Injection, tildrakizumab, 1 mg81$36,637,3150.34%339,7293,800
J0179Injection, brolucizumab-dbll, 1 mg217$34,837,9630.33%140,462498
Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units977$33,495,1000.31%4,829,3603,440
Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg226$33,320,5770.31%823,6123,017
J9041Injection, bortezomib, 0.1 mg390$32,003,4520.30%896,5051,733
J0517Injection, benralizumab, 1 mg148$31,779,9440.30%234,2771,248
J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg866$31,154,5810.29%2,274,0081,727
J2323Injection, natalizumab, 1 mg42$28,398,4890.27%1,616,83717,700
J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg1,842$28,297,0680.27%3,339,1101,296
J7327Hyaluronan or derivative, monovisc, for intra-articular injection, per dose970$27,946,2140.26%46,29632
J2182Injection, mepolizumab, 1 mg150$27,626,1880.26%1,217,9196,950
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units911$27,388,4320.26%4,105,9882,600

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Descriptions of HCPCS Level II codes are the official CMS descriptors, shown verbatim; CPT codes show a ClaimLight category in place of the descriptor. Data year 2021.

Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed